Option Care Health (OPCH) Competitors

Option Care Health (NASDAQ:OPCH) and Amedisys (NASDAQ:AMED) are both mid-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, earnings, dividends, profitability, risk, valuation, analyst recommendations and community ranking.

Which has more risk & volatility, OPCH or AMED?

Option Care Health has a beta of 1.32, indicating that its stock price is 32% more volatile than the S&P 500. Comparatively, Amedisys has a beta of 0.78, indicating that its stock price is 22% less volatile than the S&P 500.

Do analysts recommend OPCH or AMED?

Option Care Health presently has a consensus price target of $30.83, suggesting a potential upside of 40.92%. Amedisys has a consensus price target of $100.67, suggesting a potential upside of 11.85%. Given Option Care Health's stronger consensus rating and higher possible upside, analysts clearly believe Option Care Health is more favorable than Amedisys.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Option Care Health	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Amedisys	0 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.20

Does the media favor OPCH or AMED?

In the previous week, Option Care Health had 1 more articles in the media than Amedisys. MarketBeat recorded 10 mentions for Option Care Health and 9 mentions for Amedisys. Option Care Health's average media sentiment score of 1.67 beat Amedisys' score of 0.03 indicating that Option Care Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Option Care Health	9 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Amedisys	6 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has higher valuation and earnings, OPCH or AMED?

Option Care Health has higher revenue and earnings than Amedisys. Option Care Health is trading at a lower price-to-earnings ratio than Amedisys, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Option Care Health	$4.30B	0.87	$267.09M	$1.19	18.39
Amedisys	$2.24B	1.32	-$9.75M	$2.52	35.71

Do insiders and institutionals believe in OPCH or AMED?

98.1% of Option Care Health shares are held by institutional investors. Comparatively, 94.4% of Amedisys shares are held by institutional investors. 0.6% of Option Care Health shares are held by insiders. Comparatively, 1.8% of Amedisys shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Is OPCH or AMED more profitable?

Option Care Health has a net margin of 4.37% compared to Amedisys' net margin of 3.57%. Option Care Health's return on equity of 15.30% beat Amedisys' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Option Care Health	4.37%	15.30%	6.57%
Amedisys	3.57%	12.20%	6.74%

Does the MarketBeat Community believe in OPCH or AMED?

Amedisys received 442 more outperform votes than Option Care Health when rated by MarketBeat users. However, 60.23% of users gave Option Care Health an outperform vote while only 58.72% of users gave Amedisys an outperform vote.

Company	Underperform	Outperform
Option Care Health	Outperform Votes 53 60.23%	Underperform Votes 35 39.77%
Amedisys	Outperform Votes 495 58.72%	Underperform Votes 348 41.28%

Summary

Option Care Health beats Amedisys on 12 of the 18 factors compared between the two stocks.